Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-11-01
著者
-
KANEKO Shuichi
Kanazawa University Graduate School of Medicine
-
Iwahashi Hiromi
Department Of Internal Medicine And Molecular Science Osaka University Graduate School Of Medicine
-
Kawata Sumio
Department Of Gastroenterology Faculty Of Medicine Yamagata University
-
Kawata S
Second Department Of Internal Medicine Yamagata University School Of Medicine
-
Hayashi Noriyuki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kihara Shinji
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kihara Shinji
大阪大学 医学系研究科消化器内科学
-
KURASHIGE Nao
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
OZE Tsugiko
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
OSHITA Masahide
Osaka Police Hospital
-
MITA Eiji
National Hospital Organization Osaka National Hospital
-
YOSHIHARA Harumasa
Osaka Rousai Hospital
-
IMAI Yasuharu
Ikeda Municipal Hospital
-
TAMURA Shinji
Minoh Municipal Hospital
-
INUI Yoshiaki
Hyogo Prefectural Nishinomiya Hospital
-
INOUE Atsuo
Osaka General Medical Center
-
TATSUMI Tomohide
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
MIYAGI Takuya
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
KATAYAMA Kazuhiro
Osaka Kouseinenkin Hospital
-
KUBOTA SHINJI
Kansai Rousai Hospital
-
Haruna Yoshimichi
大阪大学 医学系研究科消化器内科学
-
Hayashi Eijirou
大阪大学
-
Hiramatsu Naoki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Hayashi Norio
大阪大学 医学系研究科消化器内科
-
Hiramatsu Naoki
大阪大学 医学系研究科消化器内科
-
Inui Y
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Imai Yasuharu
大阪大学 医学系研究科消化器内科
-
Inoue Yuko
大阪大学 医学系研究科消化器内科
-
Kanto Tatsuya
大阪大学 医学系研究科消化器内科
-
Kanto Tatsuya
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kiso Shinichi
Second Department Of Internal Medicine Osaka University Medical School
-
Kubota Shinji
大阪大学 医学系研究科消化器内科学
-
Kurashige Nao
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kurashige Nao
大阪大学 医学系研究科消化器内科
-
Mita Eiji
大阪大学 医学系研究科消化器内科
-
Yakushijin Takayuki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Yakushijin Takayuki
大阪大学 医学系研究科消化器内科
-
Tamura Shinji
大阪大学 医学系研究科消化器内科学
-
Tamba Sachiko
Minoh Municipal Hospital
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University
-
Takehara Tetsuo
京都府立医科大学 消化器内科学
-
Oze Tsugiko
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Oze Tsugiko
大阪大学 医学系研究科消化器内科
-
Oshita Masahide
Department Of Internal Medicine Osaka Police Hospital
-
Oshita Masahide
大阪大学 医学系研究科消化器内科
-
Katayama Kazuhiro
大阪大学 医学系研究科消化器内科学
-
Inui Yoshiaki
大阪大学 医学系研究科消化器内科
-
Hagiwara Hideki
Department Of Gastroenterology Higashiosaka City General Hospital
-
Hagiwara Hideki
大阪大学 医学系研究科消化器内科
-
Tsuji Shingo
大阪大学 医学系研究科消化器内科学
-
Tsuji S
Department Of Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Tsuji Shingo
大阪大学 医学部 保健学科 病態生体情報学
-
Kawamura Kiyomi
大阪大学 医学系研究科消化器内科学
-
Kasahara A
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Inoue Yuko
Department Of Chemistry Faculty Of Science And Engineering Saga University
-
Iio Sadaharu
First Department Of Medicine Osaka University Medical School
-
Kihara Shinji
Department Of Metabolic Medicine
-
Tsuda Kyo
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Hayashi N
Institute Of Gastroenterology Tokyo Women's Medical University
-
Kawata S
Department Of Gastroenterology Faculty Of Medicine Yamagata University
-
Kawata S
Department Of Gastroenterology Yamagata University School Of Medicine
-
Imai Y
Department Of Internal Medicine Ikeda Municipal Hospital
-
Ishikawa Yoichiro
Department Of Surgery School Of Medicine Keio University
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Tamura Shinji
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University Medical S
-
Kiso Shinichi
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University Medical S
-
Hayashi Naoaki
Division Of Medicine Institute Of Gastroenterology Tokyo Women's Medical University
-
Yotsuyanagi Hiroshi
National Hospital Organization Nagasaki Medical Center
-
Kiso Shinichi
Department Of Metabolic Medicine Osaka University Graduate School Of Medicine
-
Mochizuki Kiyoshi
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Tamura Shinji
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University
-
Kasahara Akinori
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Imai Yutaka
Department Of Gastroenterology Ikeda Municipal Hospital
-
Kaneko Akira
Department Of Gastroenterology Osaka National Hospital
-
Miyagi Takuya
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Hayashi Nobuhiko
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kihara Shinji
Department Of Metabolic Medicine Osaka University
-
Hayashi Norio
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University
-
Katayama Kazuhiro
Department Of Gastroenterology And Hepatology Osaka Koseinenkin Hospital
-
Hayashi Nobuhiko
Department Of Gastroenterology Osaka University
-
Yoshihara Harumasa
Department Of Internal Medicine Osaka Rosai Hospital
-
Yoshihara Harumasa
Department Of Gastroenterology And Metabology Ehime University Graduate School Of Medicine
-
HAGIWARA Hideki
Kansai Rousai Hospital
-
HAYASHI Norio
Kansai Rousai Hospital
-
Tatsumi Tomohide
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Hayashi Norio
The 1st Department Of Medicine Osaka University Medical School
-
Katayama Kazuhiro
Osaka Kosei-nenkin Hospital
-
Kimura Shinya
Department Of Internal Medicine And Molecular Science Osaka University Graduate School Of Medicine
-
Yoshihara Harumasa
Osaka Rosai Hospital
-
Katayama Kazuhiro
Department Of Gastroenterology Sumitomo Hospital
-
TAKEHARA Tetsuo
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
YAKUSHIJIN Takayuki
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine 2-2
-
HAGIWARA Hideki
Kansai Rosai Hospital
-
YOSHIHARA Harumasa
Osaka Police Hospital
-
TAMURA Shinji
Minoh City Hospital
関連論文
- PE-152 Adiponectin Deficiency Suppresses ABCA1 Expression and ApoA-I Synthesis in the Liver(Atherosclerosis, basic(04)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-092 Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice(Renal Dysfunction and Cardiovascular Disease(H),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation S
- Reciprocal Relationship between Adiponectin and C-Reactive Protein
- Adiponectin : A Key Molecule of the Metabolic Syndrome
- Contribution of Adiponectin Gene Mutation to Coronary Artery Disease
- Association of Adiponectin Mutation with the Metabolic Syndrome
- Adiponectin Dysregulation as a Common Cause of Insulin Resistance and Atherosclerosis
- Role of Adiponectin in Preventing Vascular Stenosis : The Missing Link of Adipo-Vascular Axis
- A Common P2 Promoter Polymorphism of the Hepatocyte Nuclear Factor-4α Gene Is Associated with Insulin Secretion in Non-Obese Japanese with Type 2 Diabetes
- Novel ELISA for Apo B-48 Revealed Chylomfcron Remnants (CR) Are Accumulated in the Plasma of Diabetic Patients despite Normolipidemia
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Reply to Letter Regarding Article, "Clinical Significance of High-Molecular Weight Form of Adiponection in Male Patients With Coronary Artery Disease"(Author's Reply)
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- Analysis of Expression Profiles of Islet-associated Transcription and Growth Factors During β-Cell Neogenesis from Duct Cells in Partially Duct-ligated Mice
- Successful Use of ^In-Pentetrotide Scintigraphy for Localizing Ectopic Adrenocorticotropin-Producing Bronchial Carcinoid Tumor in a Patient with Cushing's Syndrome
- β Cell Neogenesis from Ducts and Phenotypic Conversion of Residual Islet Cells in the Adult Pancreas of Glucose Intolerant Mice Induced by Selective Alloxan Perfusion
- Acute Pancreatitis and Hyperchylomicronemia
- Chronic Inflammatory Demyelinating Polyneuropathy Accompanied by Hepatocellular Carcinoma
- PGC-1α Gly482Ser Polymorphism Is Associated with the Plasma Adiponectin Level in Type 2 Diabetic Men
- Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C
- A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Clinical Significance of High-Molecular Weight Form of Adiponectin in Male Patients With Coronary Artery Disease
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
- Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
- Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial
- Inflammatory cytokines modulate chemokine production patterns of HepG2 cells toward initially inclined direction
- Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver disease
- Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4+CD25+ T cells in patients with autoimmune hepatitis
- Expression of Rab5a in hepatocellular carcinoma : Possible involvement in epidermal growth factor signaling
- Development of complementary expression patterns of E- and N-cadherin in the mouse liver
- Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection
- The SHAP-hyaluronan complex in serum from patients with chronic liver diseases caused by hepatitis virus infection
- Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection
- Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
- Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
- Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
- Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C
- PJ-679 Clinical Significance of High Molecular Weight Form of Adiponectin in Male Patients with Coronary Artery Disease(Diabetes / Obesity / Metabolic syndrome(14)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
- PE-347 Association of Hypoadiponectinemia with Smoking Habit in Men(Diabetes/Obesity/Metabolic syndrome-6 (H) PE58,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Plasma Adiponectin Concentration and Renal Function, and its Predictive Role in Cardiovascular Disease (Kidney/Renal Circulation 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Plasma Adiponectin and Adrenomedullin Levels in Peripheral Arterial Occlusive Disease(Peripheral Circulation/Vascular Disease 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Adiponectin as a Biomarker of the Metabolic Syndrome
- OE-031 The Decrease of Plasma Adiponectin Predicts Future Adverse Events in Patients with Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Pathophysiology) 1 (IHD) : OE4)(Oral Presentation (English))
- Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus
- Influence of a Novel Adipocyte-Derived Protein, Adiponectin on Fibrinolysis and Inflammation in Stable Effort Angina
- The Levels of Adipocyte-Derived Plasma Protein, Adiponectin, Have a Close Relation with Atherosis Rather Than Sclerosis
- OE-311 Adiponectin predicts myocardial salvage following successful reperfusion in patients with acute myocardial infarction(Myocardial ischemia/reperfusion, basic/clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japa
- PJ-636 Adiponectin : a Predictor of Cardiac Remodeling in Humans with Chronic Systolic Heart Failure(Heart failure, clinical-17, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-431 Role of Adiponectin in the Development of Chronic Heart Failure(Heart failure, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-071 Accumulation and Expression of Adiponectin in Damaged Cardiac Tissue Following Ischemia-reperfusion(Myocardial ischemia/reperfusion, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells
- Role of Vα14^+ NKT cells in the development of Hepatitis B virus-specific CTL : activation of Vα14^+ NKT cells promotes the breakage of CTL tolerance
- Association of Hypo-Adiponectinemia with Coronary Artery Disease in Women
- A Novel Plasma Protein Abundantly Expressed in Visceral Fat, Visfatin, Associated with Coronary Artery Disease
- Hypo-adiponectinemia as an Independent Coronary Risk Factor in Osaka CAD Study Group
- Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism : Is there a link?
- Lower Plasma Adiponectin Concentration Increases Risk for Hypertension
- Hepatitis B virus genotype G is an extremely rare genotype in Japan
- Home lactulose enema : prevention of hepatic encephalopathy at home
- Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat : possible role in amelioration of insulin resistance and hepatic steatosis
- Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using ^Tc-GSA SPECT in patients with acute hepatic damage
- Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver
- Successful percutaneous radiofrequency ablation of adrenal metastasis from hepatocellular carcinoma
- Reduction of serum ghrelin concentration during interferon-α therapy in patients with chronic hepatitis C
- Expression of Notch signalling markers in bone marrow cells that differentiate into a liver cell lineage in a rat transplant model
- Transmission of hepatitis C virus quasispecies between human adults
- Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma
- The Protective Role of Glutathione Peroxidase in Ppoptosis Induced by Reactive Oxygen Species^1
- PE-227 Impact of Hypoadiponectinemia on Altered Cardiac Fatty Acid Metabolism in Obesity(Nuclear cardiology(04)(I),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-255 Association of Serum Adiponectin and Matrix Metalloproteinases-9 Levels with Left Ventricular Remodeling after Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-1, The 71st Annual Scientific Meeting of the Japanese
- Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice
- Adiponectin Acts as a PDGF-BB Binding Protein, and Regulates Growth Factor-Induced Post-Receptor Signal in Vascular Smooth Muscle Cell
- The Metabolic Syndrome in Japanese and the Role of Adipocytokines
- Marked Differences In Visceral Fat Accumulation-Related Cardiovascular Risk Factors between Young and Elderly Patientswith Coronary Artery Disease
- A Plasma Protein Abundantly Expressed in Visceral Fat, Visfatin Modulates Inflammatory Response in Human Monocyte-derived Macrophages
- RECS1 deficiency in mice induces susceptibility to cystic medial degeneration
- A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- SHORT-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR EARLY GASTRIC NEOPLASM : MULTICENTER SURVEY BY OSAKA UNIVERSITY ESD STUDY GROUP
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group
- The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
- Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
- Association of low serum adiponectin levels with erosive esophagitis in men : an analysis of 2405 subjects undergoing physical check-ups
- Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
- Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin